Envoy Medical, Inc. (COCH) vs ImageneBio Inc (IMA)

A side-by-side comparison of Envoy Medical, Inc. and ImageneBio Inc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — COCH vs IMA

growth of $100 · dividends reinvested · last 5y
COCH -93.3% (-41.8%/yr)IMA -98.2% (-55.3%/yr)COCH compounded faster over this window
050100Start $10020222023202420252026$7$2
COCH IMA

COCH vs IMA: by the numbers

  • •IMA is the larger company ($54M vs $51M market cap).
  • •Both run net losses; IMA's is the smaller (-5668.62% vs -11304.83% net margin).

Metrics side by side

Valuation

MetricCOCHIMA
P/S ratio247.99N/A
P/B ratio15.540.38

Profitability

MetricCOCHIMA
Gross margin-262.66%-29.12%
Operating margin-9240.66%-6056.37%
Net margin-11304.83%-5668.62%
ROE-708.48%-36.94%
ROIC-208.76%-40.53%

Growth (annualized)

MetricCOCHIMA
Total return CAGR (5Y)-41.73%-50.73%

Frequently asked

How have COCH and IMA total returns compared?
Over the past 5 years, COCH delivered -41.73% and IMA delivered -50.73% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.